Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease

JAMA Neurology

Volumn 70, Issue 11, 2013, Pages 1382-1388

  Marder, Karen ^a,c   Gu, Yian ^b   Eberly, Shirley ^d   Tanner, Caroline M ^e   Scarmeas, Nikolaos ^a,c,f   Oakes, David ^e   Shoulson, Ira ^g  

^a Departments of Neurology and Psychiatry Columbia University College of Physicians and Surgeons ^*  (United States)

^b Department of Medicine   (United States)

^c Vagelos College of Physicians and Surgeons   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e PARKINSON S INSTITUTE   (United States)

^f UNIVERSITY OF ATHENS   (Greece)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; MONOUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CAG REPEAT; CALORIC INTAKE; CEREAL; COHORT ANALYSIS; CONTROLLED STUDY; DAIRY PRODUCT; EDUCATIONAL STATUS; FEMALE; FISH; FOOD FREQUENCY QUESTIONNAIRE; FRUIT; HUMAN; HUNTINGTON CHOREA; LEGUME; MAJOR CLINICAL STUDY; MALE; MEAT; MEDITERRANEAN DIET; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; VEGETABLE;

EID: 84888860056     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.3487     Document Type: Article

References (39)

1. Petersén A, Björkqvist M. Hypothalamic-endocrine aspects in Huntington's disease. Eur J Neurosci. 2006;24(4):961-967.
2. Sathasivam K, Hobbs C, Mangiarini L, et al. Transgenic models of Huntington's disease. Philos Trans R Soc Lond B Biol Sci. 1999;354(1386):963- 969.
3. Underwood BR, Broadhurst D, Dunn WB, et al. Huntington disease patients and transgenicmice have similar pro-catabolic serum metabolite profiles. Brain. 2006;129(pt 4):877-886.
4. Morales LM, Estévez J, Suárez H, Villalobos R, Chacín de Bonilla L, Bonilla E. Nutritional evaluation of Huntington disease patients. Am J Clin Nutr. 1989;50(1):145-150.
5. Hamilton JM, Wolfson T, Peavy GM, Jacobson MW, Corey-Bloom J; Huntington Study Group. Rate and correlates of weight change in Huntington's disease. J Neurol Neurosurg Psychiatry. 2004;75(2):209-212.
6. Robbins AO, Ho AK, Barker RA. Weight changes in Huntington's disease. Eur J Neurol. 2006;13(8):e7.
7. Djoussé L, Knowlton B, Cupples LA, Marder K, Shoulson I, Myers RH. Weight loss in early stage of Huntington's disease. Neurology. 2002;59(9):1325-1330.
8. Trejo A, Tarrats RM, Alonso ME, Boll MC, Ochoa A, Velásquez L. Assessment of the nutrition status of patients with Huntington's disease. Nutrition. 2004;20(2):192-196.
9. Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T, Roos RA; EHDI Study Group. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology. 2008;71(19):1506-1513.
10. Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I; Huntington Study Group. Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants. Neurology. 2009;73(5):385-392.
11. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology. 1990;1(1):58-64.
12. Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol. 1990;43(12):1327-1335.
13. Huntington Study Group PHAROS Investigators. At risk for Huntington disease: the Huntington Study Group PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled. Arch Neurol. 2006;63(7):991-996.
14. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol. 2006;59(6):912-921.
15. Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord. 2012;27(6):771-774.
16. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348(26):2599-2608.
17. Roman B, Carta L, Martínez-González MA, Serra-Majem L. Effectiveness of the Mediterranean diet in the elderly. Clin Interv Aging. 2008;3(1):97-109.
18. Mochel F, Haller RG. Energy deficit in Huntington disease: why it matters. J Clin Invest. 2011;121(2):493-499.
19. Hogarth P, Kayson E, Kieburtz K, et al. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Mov Disord. 2005;20(3):293-297.
20. Scarmeas N, Luchsinger JA, Schupf N, et al. Physical activity, diet, and risk of Alzheimer disease. JAMA. 2009;302(6):627-637.
21. Gu Y, Luchsinger JA, Stern Y, Scarmeas N. Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. J Alzheimers Dis. 2010;22(2):483-492.
22. Willett W, Stampfer M. Implications of total energy intake for epidemiological analyses. In: Willett W, ed. Nutritional Epidemiology. New York: Oxford University Press; 1998:273-301.
23. Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009;66(2):216-225.
24. Scarmeas N, Luchsinger JA, Stern Y, et al. Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol. 2011;69(2):257-268.
25. Gardener H, Wright CB, Gu Y, et al. Mediterranean-style diet and risk of ischemic stroke,myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr. 2011;94(6):1458-1464.
26. Scarmeas N, Louis ED. Mediterranean diet and essential tremor. A case-control study. Neuroepidemiology. 2007;29(3-4):170-177.
27. Sánchez-Moreno C, Cano MP, de Ancos B, et al. Mediterranean vegetable soup consumption increases plasma vitamin C and decreases F2-isoprostanes, prostaglandin E2 and monocyte chemotactic protein-1 in healthy humans. J Nutr Biochem. 2006;17(3):183-189.
28. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in themetabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440-1446.
29. Buruma OJ, Van der Kamp W, Barendswaard EC, Roos RA, Kromhout D, Van der Velde EA. Which factors influence age at onset and rate of progression in Huntington's disease? J Neurol Sci. 1987;80(2-3):299-306.
30. Zgaga L, Theodoratou E, Kyle J, et al. The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study. PLoS One. 2012;7(6):e38123.
31. Auinger P, Kieburtz K, McDermott MP. The relationship between uric acid levels and Huntington's disease progression. Mov Disord. 2010;25(2):224-228.
32. Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A. Diet and Parkinson's disease: a potential role of dairy products in men. Ann Neurol. 2002;52(6):793-801.
33. Chen H, O'Reilly E, McCullough ML, et al. Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol. 2007;165(9):998-1006.
34. Park M, Ross GW, Petrovitch H, et al. Consumption ofmilk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005;64(6):1047-1051.
35. Gao X, Chen H, Choi HK, Curhan G, Schwarzschild MA, Ascherio A. Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol. 2008;167(7):831-838.
36. Mochel F, Charles P, Seguin F, et al. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One. 2007;2(7):e647.
37. Tasset I, Pontes AJ, Hinojosa AJ, de la Torre R, Túnez I. Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington's disease-like rat model. Nutr Neurosci. 2011;14(3):106-111.
38. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR; International Huntington's Disease Collaborative Group. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet. 2004;65(4):267-277.
39. Paulsen JS, Langbehn DR, Stout JC, et al; Predict-HD Investigators and Coordinators of the Huntington Study Group. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry. 2008;79(8):874-880.